Goal-Directed Versus Self-Directed Valsalva Maneuver in Patients With Hypertrophic Cardiomyopathy on Cardiac Myosin Inhibitor Therapy. [PDF]
Bavishi A +9 more
europepmc +1 more source
Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy. [PDF]
Finnigan LEM +5 more
europepmc +1 more source
Incidence of Ventricular Arrhythmias and Sudden Cardiac Death with Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. [PDF]
Katic J, Bulum T, Borovac JA.
europepmc +1 more source
Mavacamten as an Effective Treatment for HCM With Latent Exercise-Induced Obstruction: A Case Report. [PDF]
Murthy N +4 more
europepmc +1 more source
Osimertinib induces reversible cardiac dysfunction through the GATA4-MYLK3-MYL2 axis. [PDF]
Zhang K +20 more
europepmc +1 more source
Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs [PDF]
Bracke, Marc +3 more
core +2 more sources
When enough is more than enough. The hidden side of the cardiac effects of intense physical exercise [PDF]
Cavarretta, Elena +3 more
core +1 more source
Spatial control of myosin regulatory light chain phosphorylation modulates cardiac thick filament mechanosensing. [PDF]
Squarci C +4 more
europepmc +1 more source
Non-muscle myosin II is a promising therapeutic target. [PDF]
Miller CA +2 more
europepmc +1 more source

